Paushak Share Price
Sector: Chemical Manufacturing
4638.45 +38.50 (0.84%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
4500.00
Today’s High
4649.00
52 Week Low
3746.00
52 Week High
6385.00
Key Metrics
- Market Cap (In Cr) 1429.62
- Beta 1.2
- Div. Yield (%) 0.43
- P/B 3.05
- TTM P/E 28.2
- Peg Ratio 3.02
- Sector P/E 17.01
- D/E 0
- Open Price 4600.05
- Prev Close 4599.95
Paushak Analysis
Price Analysis
-
1 Week5.06%
-
3 Months7.3%
-
6 Month-9.09%
-
YTD-7.17%
-
1 Year-11.76%
Risk Meter
- 45% Low risk
- 45% Moderate risk
- 45% Balanced Risk
- 45% High risk
- 45% Extreme risk
Paushak News
Specialty Chemical stock declares highest ever dividend of ₹17.50 per share: Do you own?
1 min read . 04 May 2023Paushak Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 210.95
- Selling/ General/ Admin Expenses Total
- 35.48
- Depreciation/ Amortization
- 14.97
- Other Operating Expenses Total
- 71.81
- Total Operating Expense
- 166.27
- Operating Income
- 44.68
- Net Income Before Taxes
- 58.77
- Net Income
- 49.37
- Diluted Normalized EPS
- 160.21
- Period
- 2025
- Total Assets
- 571.98
- Total Liabilities
- 106.49
- Total Equity
- 465.49
- Tangible Book Valueper Share Common Eq
- 1510.13
- Period
- 2025
- Cashfrom Operating Activities
- 37.59
- Cashfrom Investing Activities
- -56.96
- Cashfrom Financing Activities
- 18.75
- Net Changein Cash
- -0.61
- Period
- 2024
- Total Revenue
- 206.26
- Selling/ General/ Admin Expenses Total
- 59.81
- Depreciation/ Amortization
- 13.84
- Other Operating Expenses Total
- 8.6
- Total Operating Expense
- 154.97
- Operating Income
- 51.29
- Net Income Before Taxes
- 70.99
- Net Income
- 54.35
- Diluted Normalized EPS
- 176.65
- Period
- 2024
- Total Assets
- 481.35
- Total Liabilities
- 73.22
- Total Equity
- 408.12
- Tangible Book Valueper Share Common Eq
- 1324.02
- Period
- 2024
- Cashfrom Operating Activities
- 56.03
- Cashfrom Investing Activities
- -50.49
- Cashfrom Financing Activities
- -5.45
- Net Changein Cash
- 0.1
- Period
- 2023
- Total Revenue
- 212.35
- Selling/ General/ Admin Expenses Total
- 59.09
- Depreciation/ Amortization
- 13.42
- Other Operating Expenses Total
- 3.27
- Total Operating Expense
- 150.49
- Operating Income
- 61.86
- Net Income Before Taxes
- 72.22
- Net Income
- 54.01
- Diluted Normalized EPS
- 171.27
- Period
- 2023
- Total Assets
- 414.74
- Total Liabilities
- 61.05
- Total Equity
- 353.69
- Tangible Book Valueper Share Common Eq
- 1147.29
- Period
- 2023
- Cashfrom Operating Activities
- 42.71
- Cashfrom Investing Activities
- -38.2
- Cashfrom Financing Activities
- -4.05
- Net Changein Cash
- 0.46
- Period
- 2022
- Total Revenue
- 150.1
- Selling/ General/ Admin Expenses Total
- 43.1
- Depreciation/ Amortization
- 9.03
- Other Operating Expenses Total
- 1.7
- Total Operating Expense
- 104.73
- Operating Income
- 45.37
- Net Income Before Taxes
- 50.28
- Net Income
- 37.61
- Diluted Normalized EPS
- 122.23
- Period
- 2022
- Total Assets
- 366.52
- Total Liabilities
- 60.96
- Total Equity
- 305.56
- Tangible Book Valueper Share Common Eq
- 990.98
- Period
- 2022
- Cashfrom Operating Activities
- 43.97
- Cashfrom Investing Activities
- -42.35
- Cashfrom Financing Activities
- -1.74
- Net Changein Cash
- -0.12
- Period
- 2021
- Total Revenue
- 141
- Selling/ General/ Admin Expenses Total
- 40.68
- Depreciation/ Amortization
- 4.96
- Other Operating Expenses Total
- 1.41
- Total Operating Expense
- 95.49
- Operating Income
- 45.51
- Net Income Before Taxes
- 51.59
- Net Income
- 37.3
- Diluted Normalized EPS
- 120.75
- Period
- 2021
- Total Assets
- 328.76
- Total Liabilities
- 57.1
- Total Equity
- 271.66
- Tangible Book Valueper Share Common Eq
- 880.82
- Period
- 2021
- Cashfrom Operating Activities
- 29.8
- Cashfrom Investing Activities
- -28.57
- Cashfrom Financing Activities
- -1.85
- Net Changein Cash
- -0.62
- Period
- 2020
- Total Revenue
- 137.91
- Selling/ General/ Admin Expenses Total
- 34.43
- Depreciation/ Amortization
- 4.38
- Other Operating Expenses Total
- 1.08
- Total Operating Expense
- 99.42
- Operating Income
- 38.49
- Net Income Before Taxes
- 45.37
- Net Income
- 34.91
- Diluted Normalized EPS
- 107.28
- Period
- 2020
- Total Assets
- 269.83
- Total Liabilities
- 42.59
- Total Equity
- 227.24
- Tangible Book Valueper Share Common Eq
- 737.06
- Period
- 2020
- Cashfrom Operating Activities
- 41.31
- Cashfrom Investing Activities
- -39.19
- Cashfrom Financing Activities
- -1.85
- Net Changein Cash
- 0.27
- Period
- 2025-03-31
- Total Revenue
- 52.36
- Selling/ General/ Admin Expenses Total
- 9.23
- Depreciation/ Amortization
- 3.7
- Other Operating Expenses Total
- 18.21
- Total Operating Expense
- 40.18
- Operating Income
- 12.18
- Net Income Before Taxes
- 12.23
- Net Income
- 9.61
- Diluted Normalized EPS
- 31.16
- Period
- 2025-03-31
- Total Assets
- 571.98
- Total Liabilities
- 106.49
- Total Equity
- 465.49
- Tangible Book Valueper Share Common Eq
- 1510.13
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 37.59
- Cashfrom Investing Activities
- -56.96
- Cashfrom Financing Activities
- 18.75
- Net Changein Cash
- -0.61
- Period
- 2024-12-31
- Total Revenue
- 49.26
- Selling/ General/ Admin Expenses Total
- 9.32
- Depreciation/ Amortization
- 3.76
- Other Operating Expenses Total
- 17.03
- Total Operating Expense
- 38.34
- Operating Income
- 10.92
- Net Income Before Taxes
- 17.2
- Net Income
- 15.27
- Diluted Normalized EPS
- 49.51
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 57.31
- Selling/ General/ Admin Expenses Total
- 8.41
- Depreciation/ Amortization
- 3.77
- Other Operating Expenses Total
- 19.12
- Total Operating Expense
- 44.04
- Operating Income
- 13.27
- Net Income Before Taxes
- 16.89
- Net Income
- 14.2
- Diluted Normalized EPS
- 46.09
- Period
- 2024-09-30
- Total Assets
- 512.06
- Total Liabilities
- 75.29
- Total Equity
- 436.77
- Tangible Book Valueper Share Common Eq
- 1416.89
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 25.23
- Cashfrom Investing Activities
- -19.61
- Cashfrom Financing Activities
- -6.06
- Net Changein Cash
- -0.44
- Period
- 2024-06-30
- Total Revenue
- 52.01
- Selling/ General/ Admin Expenses Total
- 8.52
- Depreciation/ Amortization
- 3.73
- Other Operating Expenses Total
- 17.43
- Total Operating Expense
- 43.69
- Operating Income
- 8.32
- Net Income Before Taxes
- 12.45
- Net Income
- 10.31
- Diluted Normalized EPS
- 33.44
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 53.82
- Selling/ General/ Admin Expenses Total
- 7.89
- Depreciation/ Amortization
- 3.62
- Other Operating Expenses Total
- 17.36
- Total Operating Expense
- 38.44
- Operating Income
- 15.38
- Net Income Before Taxes
- 22.51
- Net Income
- 18.25
- Diluted Normalized EPS
- 59.23
- Period
- 2024-03-31
- Total Assets
- 481.35
- Total Liabilities
- 73.22
- Total Equity
- 408.12
- Tangible Book Valueper Share Common Eq
- 1324.02
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 56.03
- Cashfrom Investing Activities
- -50.49
- Cashfrom Financing Activities
- -5.45
- Net Changein Cash
- 0.1
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Paushak Technical
Moving Average
SMA
- 5 Day4542.85
- 10 Day4431.13
- 20 Day4498.8
- 50 Day4418.94
- 100 Day4592.17
- 300 Day5057.71
Paushak Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Astec Lifesciences
- 698
- -13.3
- -1.87
- 1487.65
- 635.95
- 1368.22
- Punjab Chemicals And Crop Prot
- 1132.55
- -18.25
- -1.59
- 1575
- 669.55
- 1387.21
- Paushak
- 4638.45
- 38.5
- 0.84
- 6385
- 3746
- 1429.62
- Heubach Colorants India
- 588.05
- 1.85
- 0.32
- 733.25
- 355.15
- 1361.49
- J.g.chemicals
- 340
- -1.6
- -0.47
- 484
- 200.1
- 1331.36
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Astec Lifesciences
- -
- 6.1
- -0.07
- -0.04
- Punjab Chemicals And Crop Prot
- 34.05
- 3.92
- 23.61
- 6.43
- Paushak
- 28.86
- 3.06
- 13.8
- 25.27
- Heubach Colorants India
- 33.16
- 2.88
- 13.92
- 8.77
- J.g.chemicals
- 34.52
- 3.4
- -
- -
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 01-May-25
- Audited Results & Final Dividend
- 30-Jan-25
- Quarterly Results
- 29-Oct-24
- Quarterly Results
- 02-Aug-24
- Quarterly Results
- 03-May-24
- Audited Results & Final Dividend
- 02-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results
- 01-Aug-23
- Quarterly Results
- 04-May-23
- Audited Results & Final Dividend
- 27-Jan-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 17-May-25
- 15-Apr-25
- POM
- 02-Aug-24
- 03-Jul-24
- AGM
- 01-Aug-23
- 04-May-23
- AGM
- 09-Aug-22
- 06-May-22
- AGM
- 03-Aug-21
- 29-Jun-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 02-May-25
- -
- -
- 20
- 03-May-24
- 26-Jul-24
- 26-Jul-24
- 20
- 04-May-23
- 25-Jul-23
- 25-Jul-23
- 17.5
- 06-May-22
- 02-Aug-22
- 01-Aug-22
- 12
- 10-May-21
- -
- 26-Jul-21
- 6


